Jack Ng Kok Wah | Public Health | Best Health Science Research Award

Published on by Scientific World Research Awards

Dr. Jack Ng Kok Wah | Public Health | Best Health Science Research Award

Senior Lecturer | Multimedia University | Malaysia

 

Dr. Jack Ng Kok Wah’s research lies at the intersection of artificial intelligence (AI), surgical innovation, and biomedical engineering, with a strong emphasis on developing AI-driven robotic systems that enhance precision, reduce surgical risks, and revolutionize patient outcomes. His body of work demonstrates a deep commitment to integrating machine learning algorithms and intelligent automation into modern surgical practices, thereby addressing one of the most critical needs in healthcare—precision and safety in complex procedures.A significant aspect of his research explores how robotic technologies and AI-assisted decision systems can transform traditional surgical approaches. By leveraging real-time data analytics, sensor fusion, and computer vision, Dr. Wah contributes to the design of systems that support surgeons in performing minimally invasive procedures with unprecedented accuracy. His work not only advances the technical frontiers of robotic surgery but also examines the broader ethical, clinical, and operational implications of implementing such technologies in real-world healthcare environments.Beyond surgical robotics, Dr. Wah’s research interests extend to digital health innovation, medical imaging, and intelligent clinical systems. He investigates how data-driven approaches can improve diagnostic accuracy, predict patient outcomes, and personalize treatment protocols. Through his publications, he emphasizes the transformative potential of AI to bridge gaps between human expertise and machine efficiency, promoting a synergistic model of healthcare delivery that enhances both safety and accessibility.With a growing citation record and interdisciplinary collaborations, Dr. Wah continues to contribute to the advancement of next-generation medical technologies that merge computing power with human insight. His vision encapsulates a future where AI and robotics are not merely tools but trusted partners in surgical and clinical decision-making, ultimately redefining standards of care in the medical field. His scholarly contributions reinforce his standing as a forward-thinking researcher committed to shaping the future of intelligent healthcare systems and precision surgery.

Profiles: Scopus | ORCID | Google Scholar | ResearchGate 

Featured Publications

  1. Wah, J. N. K. (2025). Revolutionizing surgery: AI and robotics for precision, risk reduction, and innovation. Journal of Robotic Surgery, 19(Article No. 47).
    Citations: 39

  2. Wah, J. N. K. (2025). Revolutionizing e-Health: The transformative role of AI-powered hybrid chatbots in healthcare solutions. Frontiers in Public Health, 13.
    Citations: 29

  3. Wah, J. N. K. (2025). The rise of robotics and AI-assisted surgery in modern healthcare. Journal of Robotic Surgery, 19(1), 311.
    Citations: 13

  4. Ng, J., Wah, K., Fitriana, M., & Arumugam, T. (2023). Assumptions for structural equation modeling (SEM), normality of data distribution analysis & model fit measures. In Normality of Data Distribution Analysis & Model Fit Measures.
    Citations: 12

  5. Wah, K., & Ng, J. (2025). AI-driven robotic surgery in oncology: Advancing precision, personalization, and patient outcomes. Journal of Robotic Surgery, 19(1), 1–11.
    Citations: 7

Dr. Jack Ng Kok Wah envisions a future where artificial intelligence and robotic systems seamlessly integrate into healthcare, enabling safer, smarter, and more precise surgical interventions. His pioneering research drives innovations that enhance patient outcomes, optimize clinical workflows, and redefine the frontiers of intelligent medicine.

Nasser Mousa | Public Health | Best Researcher Award

Published on by Scientific World Research Awards

Prof. Dr. Nasser Mousa | Public Health | Best Paper Award

Professor | Mansoura University | Egypt

Prof. Dr. Nasser Hamed Mousa is a renowned Egyptian medical scientist and hepatologist, serving at the Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt. With a Scopus record of 1,028 citations, 47 scientific publications, and an h-index of 16, he has made exceptional contributions to the fields of hepatology, gastroenterology, metabolic diseases, and translational medicine. Prof. Mousa earned his M.B.B.Ch., M.Sc., and Ph.D. in Hepatology and Gastroenterology from leading Egyptian medical universities, where he developed a strong foundation in internal medicine and liver pathology. Over the years, he has built an impressive professional career focusing on clinical hepatology, particularly viral hepatitis, liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). His research interests encompass liver disease surveillance, nanomedicine, cancer biology, and metabolic dysfunction-associated steatotic liver disease (MASLD). Notably, his recent studies on individualized HCC risk stratification and gold nanoparticle-mediated cancer therapy have gained international recognition for their innovative clinical and molecular insights. Prof. Mousa’s research skills span molecular diagnostics, clinical trial design, bioinformatics-based network pharmacology, and predictive modeling for liver disease outcomes, reflecting his multidisciplinary expertise. His collaboration with national and international research teams underscores his leadership in evidence-based hepatology. Prof. Mousa has also contributed to advancing precision medicine approaches for patients with chronic liver disease, integrating laboratory science with clinical decision-making. Throughout his career, he has received numerous academic honors and institutional recognitions for his excellence in research, publication impact, and contribution to medical innovation. In conclusion, Prof. Dr. Nasser Hamed Mousa stands as a distinguished figure in liver research, embodying excellence in scientific inquiry, clinical innovation, and academic leadership, while his impactful body of work continues to influence global hepatology and improve patient outcomes in Egypt and worldwide.

Profiles: Scopus | ORCID 

Featured Publications

  1. Mousa, N., Elbaz, S., Elmetwalli, A., Mansour, M., Abdelsalam, M., Abdelaziz, M., Hashem, M., El-Emam, O., El-wakeel, N., Elgamal, A., et al. (2025). A risk stratification score for predicting first episode of upper gastrointestinal bleeding in patients with cirrhosis. Archives of Medical Research.

  2. Mousa, N., Elmetwalli, A., Abdel-Razik, A., Mousa, E., Abdelsalam, M., Elbaz, S., El-wakeel, N., Eldars, W., Gad, E., Arafa, M., et al. (2025, September 15). Periodontitis and metabolic dysfunction-associated steatotic liver disease: Emphasizing the clinical interplay between hepatologists and dentists. Odontology.

  3. Mousa, N., Elbaz, S., Elmetwalli, A., Abdelsalam, M., Abdelkader, E., Wahba, M., Abdelaziz, M., El-Emam, O., El-wakeel, N., Shaheen, M., et al. (2025, April 16). Neutrophil percentage-to-albumin ratio as a predictor of acute kidney injury in cirrhotic patients: A novel approach utilizing artificial intelligence. American Journal of Nephrology.

  4. Shiha, G., Mousa, N., Soliman, R., Mikhail, N. N. H., Elbasiony, M. A., & Khattab, M. (2020, July). Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study. Journal of Viral Hepatitis.

  5. Elbaz, S., Mousa, N., Besheer, T., Sheta, T., Taha, K., Awad, M., Effat, N., Elgamal, A., & Abdel-Razik, A. (2020, April 2). Malondialdehyde and C-reactive protein as prognostic markers of hepatocellular carcinoma. British Journal of Biomedical Science.